UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017551
Receipt number R000010502
Scientific Title Comparative study between non-blinded, randomized, parallel group regarding the preventive effect of the coarse-hydrochloride landiolol for atrial fibrillation after major thoracic vascular surgery
Date of disclosure of the study information 2015/05/13
Last modified on 2015/07/15 21:06:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparative study between non-blinded, randomized, parallel group regarding the preventive effect of the coarse-hydrochloride landiolol for atrial fibrillation after major thoracic vascular surgery

Acronym

Comparative study between non-blinded, randomized, parallel group regarding the preventive effect of the coarse-hydrochloride landiolol for atrial fibrillation after major thoracic vascular surgery

Scientific Title

Comparative study between non-blinded, randomized, parallel group regarding the preventive effect of the coarse-hydrochloride landiolol for atrial fibrillation after major thoracic vascular surgery

Scientific Title:Acronym

Comparative study between non-blinded, randomized, parallel group regarding the preventive effect of the coarse-hydrochloride landiolol for atrial fibrillation after major thoracic vascular surgery

Region

Japan


Condition

Condition

thoracic aortic aneurysm, thoracic aortic dissection

Classification by specialty

Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Parallel group unblinded randomized to evaluate the preventive effect coarse-postoperative atrial fibrillation in patients using a hydrochloride landiolol with Efficacy against tachyarrhythmia perioperative, who underwent thoracic vascular surgery.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The proportion of patients with atrial fibrillation coarse-until 7 days after surgery occurred.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Group treated with the hydrochloride salt landiolol

Interventions/Control_2

Group treated without the hydrochloride salt landiolol

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(a) Age at the time of obtaining informed consent of patients aged 20 years or older
(b) Patients scheduled for thoracic aortic aneurysm or dissection underwent replacement surgery.
(c)Patient consent is obtained in writing with respect to participation in the study

Key exclusion criteria

Corresponding to patient contraindications hydrochloride landiolol
Patients with acute myocardial infarction within 3 days.
Patients with supraventricular arrhythmia that might need treatment.
Patients with severe heart failure (NYHA III degrees or more just before surgery, EF less than 35%).
Patients with atrial fibrillation cause of electrolyte abnormalities, WPW syndrome and hyperthyroidism.
Diastolic blood pressure / systolic patients less than 90/60 mmHg.
Patients with severe asthma.
Patients who take an oral antiarrhythmic drugs or beta blocker.
Patients who were found to be inappropriate physician to carry out the study.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Taijiro Sueda

Organization

Hiroshima University

Division name

Institute of Biomedical and Health Sciences Applied Life Sciences Surgery

Zip code


Address

minami ku kasumi 1-2-3, hiroshima city, Hiroshima

TEL

0822575215

Email

sueda@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Keisuke Watadani

Organization

Hiroshima University

Division name

Institute of Biomedical and Health Sciences Applied Life Sciences Surgery

Zip code


Address

minami ku kasumi 1-2-3, hiroshima city, Hiroshima

TEL

0822575218

Homepage URL


Email

kwatadani@hiroshima-u.ac.jp


Sponsor or person

Institute

Hiroshima University
Institute of Biomedical and Health Sciences
Applied Life Sciences
Surgery

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 05 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2012 Year 10 Month 01 Day

Date of IRB


Anticipated trial start date

2012 Year 11 Month 01 Day

Last follow-up date

2014 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 05 Month 13 Day

Last modified on

2015 Year 07 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010502


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name